Pfizer Inc. (NYSE: PFE) will begin a new clinical trial of the pain medication Remoxy that was developed by Pain Therapeutics Inc. (Nasdaq: PTIE) and Durect Corp. (Nasdaq: DRRX). Shares of Pfizer slipped 43 cents to close at $28.37 while Pain Therapeutics stock soared 82 cents to close at $3.11. Durect stock climbed 19 cents to close at $1.24.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here